{"id":23140,"date":"2023-03-06T10:00:35","date_gmt":"2023-03-06T09:00:35","guid":{"rendered":"https:\/\/idibell.cat\/?p=23140"},"modified":"2023-03-06T10:51:06","modified_gmt":"2023-03-06T09:51:06","slug":"el-hospital-de-bellvitge-idibell-i-astrazeneca-proven-una-aplicacio-que-monitoritza-la-insuficiencia-cardiaca-mitjancant-la-veu","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2023\/03\/el-hospital-de-bellvitge-idibell-i-astrazeneca-proven-una-aplicacio-que-monitoritza-la-insuficiencia-cardiaca-mitjancant-la-veu\/","title":{"rendered":"El Hospital de Bellvitge, IDIBELL i Astrazeneca proven una aplicaci\u00f3 que monitoritza la insufici\u00e8ncia card\u00edaca mitjan\u00e7ant la veu"},"content":{"rendered":"

L’objectiu de l’app \u00e9s mantenir un control correcte de la malaltia i avisar els professionals sanitaris mitjan\u00e7ant unes alarmes visibles al quadre de comandaments que ells mateixos revisen. Gr\u00e0cies a aquest avis, es pot actuar de manera primerenca, ja que \u00e9s capa\u00e7 d’alertar fins a 18 dies abans que es registri una descompensaci\u00f3 en el pacient.<\/p>\n

La primera prova real de l\u2019app s’inicia aquest mes de mar\u00e7 gr\u00e0cies a la participaci\u00f3 de m\u00e9s de 50 pacients i se centrar\u00e0 a ensenyar el funcionament de l’eina de diagn\u00f2stic als professionals de l’Hospital de Bellvitge, el monitoratge del seguiment dels pacients i la generaci\u00f3 d’alertes aix\u00ed com la formaci\u00f3 als pacients.<\/p>\n

L’objectiu d’aquesta prova pilot, que es dur\u00e0 a terme durant 6 o 9 mesos, \u00e9s valorar la factibilitat de l’\u00fas de l’eina, que ja ha estat validada a Israel i als Estats Units i que ha estat capa\u00e7 de predir-ne un 79,6% de les recaigudes en pacients amb insufici\u00e8ncia card\u00edaca congestiva que es troben estables fins a 18 dies abans que succeeixin.<\/p>\n

El lideratge cl\u00ednic d’aquest pilot per part de l’Hospital Universitari de Bellvitge \u00e9s clau, ja que aquest desenvolupa una atenci\u00f3 integrada d’alta qualitat en pacients amb insufici\u00e8ncia card\u00edaca al si d’un Programa Territorial d’Atenci\u00f3 integrada amb Atenci\u00f3 Prim\u00e0ria dedicat a aquesta patologia, que ha demostrat reduir la mortalitat i les hospitalitzacions d’aquests pacients.<\/p>\n

La insufici\u00e8ncia card\u00edaca \u00e9s una afecci\u00f3 cr\u00f2nica que es caracteritza per la incapacitat de bombar la sang pel cos de manera efica\u00e7. Aquesta patologia afecta un 2,34% de la poblaci\u00f3 adulta espanyola i suposa la principal causa d\u2019hospitalitzaci\u00f3 en majors de 65 anys. \u00c9s fonamental establir un abordatge primerenc i un seguiment continuat de l’estat del pacient per mantenir els s\u00edmptomes sota control, evitar ingressos hospitalaris i millorar-ne la qualitat de vida. HearOTM<\/sup> \u00e9s una soluci\u00f3 digital que converteix els tel\u00e8fons m\u00f2bils en dispositius m\u00e8dics avan\u00e7ats. Mitjan\u00e7ant la seva tecnologia innovadora, es monitoritzen diferents mostres de parla de pacients, creant un aprenentatge del model de parla a trav\u00e9s de la intel\u00b7lig\u00e8ncia artificial, cosa que permetr\u00e0 analitzar les difer\u00e8ncies i detectar canvis relacionats amb la insufici\u00e8ncia card\u00edaca i alertar el metge, permetent una actuaci\u00f3 r\u00e0pida i efica\u00e7.<\/p>\n

 <\/p>\n

Bioheart, grup de recerca de malalties cardiovasculars<\/strong><\/p>\n

El Grup de Recerca en Malalties Cardiovasculars BIO-HEART<\/a> \u00e9s un grup emergent renovat dins del Programa de Recerca en malalties inflamat\u00f2ries, cr\u00f2niques i degeneratives de l’\u00c0rea de Recerca Traslacional de l’IDIBELL (Institut de Recerca Biom\u00e8dica de Bellvitge) liderat pel Dr. Josep Comin Colet . Es tracta d’un grup de recerca multidisciplinar format per professionals sanitaris dedicats al maneig i la prevenci\u00f3 de malalties cardiovasculars. L\u00b4equip de recerca inclou investigadors postdoctorals b\u00e0sics, cardi\u00f2legs cl\u00ednics i intervencionistes, infermers especialitzats, professionals de medicina comunit\u00e0ria i cardi\u00f2legs especialistes en t\u00e8cniques d\u00b4imatge per al diagn\u00f2stic de malaltia arterial coron\u00e0ria i insufici\u00e8ncia card\u00edaca de l\u00b4Hospital Universitari de Bellvitge.<\/p>\n

El grup de recerca BIO-HEART sustenta la seva activitat investigadora en un cl\u00faster s\u00f2lid de recerca cardiovascular conformat a la regi\u00f3 sanit\u00e0ria Metropolitana Sud, que compr\u00e8n 8 centres hospitalaris, coordinats per l’Hospital Universitari de Bellvitge, i m\u00e9s de 60 centres d’atenci\u00f3 prim\u00e0ria formen un centre assistencial i de recerca, xarxa que ofereix serveis d’atenci\u00f3 d’alta qualitat est\u00e0ndard a m\u00e9s de 1,5 milions de persones i serveix com a plataforma per a estudis cl\u00ednics i precl\u00ednics promoguts i coordinats pel grup. El seu principal objectiu \u00e9s reduir el risc de les malalties cardiovasculars mitjan\u00e7ant la realitzaci\u00f3 de recerca aplicada i translacional.<\/p>\n","protected":false},"excerpt":{"rendered":"

A trav\u00e9s d’un dispositiu m\u00f2bil, HearO\u2122 permet predir possibles complicacions en pacients amb insufici\u00e8ncia card\u00edaca mitjan\u00e7ant la parla, detectant l’acumulaci\u00f3 de l\u00edquid relacionada amb la malaltia i alertar el metge abans de l’hospitalitzaci\u00f3<\/p>\n","protected":false},"author":8,"featured_media":23141,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[359,334,466],"tags":[],"class_list":["post-23140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-malalties-cardiovasculars","category-medicina-translacional","category-p-de-malalties-cardiovasculars-respiratories-sistemiques-i-denvelliment-cellular"],"publishpress_future_action":{"enabled":false,"date":"2024-11-29 09:56:42","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=23140"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23140\/revisions"}],"predecessor-version":[{"id":23142,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23140\/revisions\/23142"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/23141"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=23140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=23140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=23140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}